Minhui Chen is an associate based in O’Melveny’s Beijing office, and a member of the corporate finance and capital markets group. Minhui focuses on Hong Kong and U.S. capital Markets, and general corporate matters.
Capital Markets
- Vigonvita Life Sciences Co., Ltd. (2630.HK) in its approximately HK$600 million (approximately US$77 million) IPO and listing on the Hong Kong Stock Exchange
- TransThera Sciences (2617.HK) in approximately US$25 million listing of H shares on the Hong Kong Exchange
- Zhejiang Taimei Medical Technology Co., Ltd. (2576.HK) in its approximately US$43 million IPO and listing on the Hong Kong Stock Exchange
- eHi Car Services in its US$325 million Regulation S high-yield bond offering due 2027
- Folangsi Co., Ltd (2499.HK) in its HK$155 million (approximately US$20.15 million) IPO and listing on the Hong Kong Stock Exchange
- Tiantu Capital (1973.HK) in its approximately US$144 million IPO and listing on the Hong Kong Stock Exchange, marking the first-ever listing of a PRC VC firm in Hong Kong
- Adlai Nortye Ltd. (NASDAQ: ANL) in its approximately US$100 million IPO on the Nasdaq
- CICC, CCB, CMB, CMS and other underwriters in the approximately US$150 million IPO of Beijing Fourth Paradigm Technology Co., Ltd. (6682.HK) on the Hong Kong Stock Exchange
- Rainmed Medical Limited (2297.HK) in its US$18.7 million IPO and listing on the Hong Kong Stock Exchange
- Kangqiao Service Group Limited (2205.HK) in its IPO and listing on the Hong Kong Stock Exchange*
- Ling Yue Services Group Limited (2165.HK) in its IPO and listing on the Hong Kong Stock Exchange*
- Radiance Holdings (Group) Company Limited (9993.HK) in its IPO and listing on the Hong Kong Stock Exchange*
* Work above performed prior to joining O’Melveny
Languages
- English
- Mandarin Chinese
Admissions
- New York
Education
- Northwestern University Law School, LL.M.
- China University of Political Sciences and Law, LL.M.
Professional Activities
Bar Exam
- Passed Chinese Bar Exam
Related Practices
Related Regions